Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002092017-25-000005
Filing Date
2025-11-07
Accepted
2025-11-07 16:15:14
Documents
1
Period of Report
2025-11-05

Document Format Files

Seq Description Document Type Size
1 form4-11072025_041109.html 4  
1 form4-11072025_041109.xml 4 4138
  Complete submission text file 0002092017-25-000005.txt   5512
Mailing Address 1841 PAGE MILL RD PALO ALTO CA 94304
Business Address 1841 PAGE MILL RD PALO ALTO CA 94304 (650) 223-7745
Evommune, Inc. (Issuer) CIK: 0002044725 (see all company filings)

EIN.: 850742575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1841 PAGE MILL ROAD, SUITE 100 PALO ALTO CA 94304
Business Address
Patel Jeegar Pravinkumar (Reporting) CIK: 0002092017 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42938 | Film No.: 251462840